Oncogenic lncRNA PCAT2 linked to chromosome instability in cancer

hromosome breaks and translocations are often critical factors in tumorigenesis and cancer progression. One primary contributor to these types of chromosomal instability is the mis-regulation of histone proteins. Histones are responsible for packaging the human genome into chromatin and can be divided into five main families: H1/H5, H2A, H2B, H3, and H4.

Poor prognosis and aggressive features of primary adrenal DLBCL linked to PD-L1 gene alterations

Primary adrenal (PA) lymphoma is extremely rare, accounting for less than 1% of all non-Hodgkin lymphomas, yet is very aggressive and has a poor prognosis, with a general survival time of less than one year. In most cases, PA lymphomas are derived from B cells, with diffuse large B cell lymphoma (DLBCL) being the most common phenotype.

Empire Genomics Welcomes Andre Lubarsky as US Sales Director

July 20th, Buffalo, NY – Empire Genomics, a company that develops high-quality molecular probes for fluorescent and chromogenic in situ hybridization testing, has selected Andre Lubarsky to initiate the new North American business development strategy as Director of Sales. Andre is a seasoned sales director, most recently with System Biosciences, Inc., who will now be leveraging his experience to develop and execute key growth sales strategies in the United States and North America.

Point mutation causes dramatic shift in HIV-1 integration sites

Retroviruses, such as the human immunodeficiency virus (HIV-1), insert a copy of their genome into the host cell genome during a process called integration. This allows retroviruses to persist indefinitely in the infected cell as a provirus. During integration, the virally encoded integrase (IN) protein binds to various host factors that likely act as a tether between the viral IN protein and the host chromatin at the integration site.

DTX3 amplification found in a small proportion of breast cancer patients; linked with increased proliferation

The degree of cell proliferation is one of the most powerful prognostic features in breast cancer. Deltex E3 ubiquitin ligase 3 (DTX3), a member of the Deltex family, is located on 12q13.3 and is involved in neurogenesis and Notch signaling. DTX3 has been suggested as a potential driver gene of cell proliferation in luminal subtypes of breast cancer and has been associated with poor prognosis. However, studies of DTX3 in different cancers have found different results; in esophageal cancer, DTX3 was associated with reduced proliferation of tumor cells, and in colorectal cancer, DTX3 was proposed as an endogenous control gene for gene expression analyses.

Plott syndrome caused by an interchromosomal insertion

Plott syndrome, or familial congenital bilateral laryngeal abductor paralysis, was first described by Plott and colleagues in 1964 and has been reported twice since that time. Clinical expression has been limited to male children, and inheritance patterns have suggested Plott syndrome to be an X-linked recessive disorder. However, no conclusive genetic or chromosomal aberration has been reported to date, and no genetic tests have been conducted on any of the affected families. In this case, the authors report a new family with Plott syndrome and present data to suggest that Plott syndrome is caused by a 404kb fragment inserted into the intergenic chromosomal region Xq27.1.

Clonal heterogeneity and specific chromosome gains proposed as new prognostic biomarkers for HHD-B-ALL

B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, features a substantial subgroup of patients with chromosomal gains (hyperdiploidy). Patients with a modal chromosome number >50 (high hyperdiploidy; HHD) account for nearly 30% of B-ALL cases and typically have a more favorable prognosis. Although HHD represents an important prognostic factor in childhood B-ALL, the specific chromosome gains that most contribute to a favorable clinical outcome have yet to be established.